Cited by 211Statistical Methods in Clinical TrialsAdvanced Causal Inference TechniquesSubstance Abuse Treatment and Outcomes

Developing adaptive treatment strategies in substance abuse research

Open access
Murphy, Susan A., Lynch, Kevin G., Oslin, David, McKay, James R., TenHave, Tom·2007·Drug and Alcohol Dependence

Abstract

For many individuals, substance abuse possesses characteristics of chronic disorders in that individuals experience repeated cycles of cessation and relapse; hence viewing drug dependence as a chronic, relapsing disorder is increasingly accepted. The development of a treatment for a chronic disorder requires consideration of the ordering of treatments, the timing of changes in treatment, and the use of measures of response, burden and adherence collected during treatment to make further treatment decisions. Adaptive treatment strategies provide a vehicle through which these issues can be addressed and thus provide a means toward improving and informing the clinical management of chronic substance abuse disorders. The sequential multiple assignment randomized trial (SMART) is particularly useful in developing adaptive treatment strategies. Simple analyses that can be used with the SMART design are described. Furthermore, the SMART design is compared with standard experimental designs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drugalcdep.2006.09.008

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Measurement-based care is an essential component of treatment for many chronic physical and mental health conditions, but it is not typically used in the treatment of substance use disorders.

    “Measurement-based care (Valenstein et al., 2009) is an essential component of treatment for many chronic physical and mental health conditions, but it is not typically used in the treatment of substance use disorders (SUDs)”

    From Development and initial evaluation of the Brief Addiction Monitor (BAM) (2013) · cites this paper as Murphy, Lynch, Oslin, McKay, & TenHave, 2007

    The Abstract says that treating a chronic disorder requires measures of response, burden, and adherence to guide later treatment decisions, and §2 describes using such measures in adaptive substance-use treatment. The paper does not say that measurement-based care is typically used for other physical or mental health conditions, or that it is not typically used for substance use disorders. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Many health disorders are managed through a sequential, individualized approach in which treatment is adapted and readapted over time according to the individual's needs and changing status.

    “The management of many health disorders, such as obesity, substance use, or depression, often entails a sequential, individualized approach whereby treatment (e.g., behavioral or medical interventions, or a combination) is adapted and readapted over time in response to the specific needs and evolving status of the individual [1,2].”
  • Running separate RCTs for each stage and then for the adaptive intervention as a whole is less cost-effective than using a SMART.

    “it would be less cost-effective-both in terms of actual dollars spent and, importantly, the value of the scientific information gained”
  • Recent methodological work on adaptive interventions includes development of the SMART Trial and exploration of applying engineering control algorithms to adaptive behavioral interventions.

    “Recent methodological work on building and optimizing adaptive interventions has included development of the Sequential Multiple Assignment Randomized Trial (SMART Trial) (58) and exploration of the idea of applying control algorithms from engineering to adaptive behavioral interventions to improve their performance (38, 39).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. Albert JM, Yun H. Statistical advances in AIDS therapy trials. Stat Methods Med Res. 2001;10:85–100. doi: 10.1177/096228020101000202. [DOI] [PubMed] [Google Scholar] · DOI
  2. Altfeld M, Walker BD. Less is More? STI in acute and chronic HIV-1 infection. Nat Med. 2001;7:881–884. doi: 10.1038/90901. [DOI] [PubMed] [Google Scholar] · DOI
  3. Breslin FC, Sobell MB, Sobell LC, Cunningham JA, Sdao-Jarvie K, Borson D. Problem drinkers: evaluation of a stepped-care approach. J Subst Abuse. 1999;10(3):217–232. doi: 10.1016/s0899-3289(99)00008-5. [DOI] [PubMed] [Google Scholar] · DOI
  4. Brooner RK, Kidorf M. Using Behavioral Reinforcement to Improve Methadone Treatment Participation. Sci Pract Perspect. 2002;1:38–48. doi: 10.1151/spp021138. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  5. Brown BS. Drug use – Chronic and Relapsing or a Treatable Condition. Subst Use Misuse. 1998;33(12):2215–2520. doi: 10.3109/10826089809059338. [DOI] [PubMed] [Google Scholar] · DOI
  6. Byar DP. Why data bases should not replace randomized clinical trials. Biometrics. 1980;36(2):337–342. [PubMed] [Google Scholar]
  7. Byar DP. The use of data bases and historical controls in treatment comparisons. Recent Results Cancer Res. 1988;111:95–98. doi: 10.1007/978-3-642-83419-6_12. [DOI] [PubMed] [Google Scholar] · DOI
  8. Byar DP. Problems with Using Observational Databases to Compare Treatments. Stat Med. 1991;10:663–666. doi: 10.1002/sim.4780100417. [DOI] [PubMed] [Google Scholar] · DOI
  9. Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol. 2000;35(6):587–593. doi: 10.1093/alcalc/35.6.587. [DOI] [PubMed] [Google Scholar] · DOI
  10. Collins LM, Murphy SA, Nair V, Strecher V. A Strategy for Optimizing and Evaluating Behavioral Interventions. Ann Behav Med. 2005;30:65–73. doi: 10.1207/s15324796abm3001_8. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  11. Donovan DM. Continuing Care: Promoting the Maintenance of Change. In: Miller WR, Heather N, editors. Treating Addictive Behaviors. 2. Plenum; New York: 1998. pp. 317–336. [Google Scholar]
  12. Green SB, Byar DP. Using Observational Data from Registries to Compare Treatments: The Fallacy of Omnimetrics. Stat Med. 1984;3:361–370. doi: 10.1002/sim.4780030413. [DOI] [PubMed] [Google Scholar] · DOI
  13. ICH (International conference on harmonization of technical requirements for registration of pharmaceuticals for human use) ICH harmonized tripartite guideline: statistical principles for clinical trials. Stat Med. 1999;18:1905–1942. [PubMed] [Google Scholar]
  14. Kidorf M, Neufeld K, Brooner RK. Combining stepped care approaches with behavioral reinforcement to motivate employment in opioid-dependent outpatients. Subst Use Misuse. 2004;39(13–14):2215–2238. doi: 10.1081/ja-200034591. [DOI] [PubMed] [Google Scholar] · DOI
  15. Lavori PW, Dawson R. A design for testing clinical strategies: biased individually tailored within-subject randomization. J R Stat Soc Ser A Stat Soc. 2000;163:29–38. [Google Scholar]
  16. Lavori PW, Dawson R, Rush AJ. Flexible treatment strategies in chronic disease: Clinical and research implications. Biol Psychiatry. 2000;48:605–614. doi: 10.1016/s0006-3223(00)00946-x. [DOI] [PubMed] [Google Scholar] · DOI
  17. Lavori PW, Rush AJ, Wisniewski SR, Alpert J, Fava M, Kupfer DJ, Nierenberg A, Quitkin FM, Sackeim HA, Thase ME, Trivedi M. Strengthening Clinical Effectiveness Trials: Equipoise-stratified Randomization. Biol Psychiatry. 2001;50(10):792–801. doi: 10.1016/s0006-3223(01)01223-9. [DOI] [PubMed] [Google Scholar] · DOI
  18. Lavori PW, Dawson R. Dynamic treatment regimes: practical design considerations. Clin Trials. 2004;1(1):9–20. doi: 10.1191/1740774s04cn002oa. [DOI] [PubMed] [Google Scholar] · DOI
  19. Lunceford J, Davidian M, Tsiatis AA. Estimation of the survival distribution of treatment regimes in two-stage randomization designs in clinical trials. Biometrics. 2002;58:48–57. doi: 10.1111/j.0006-341x.2002.00048.x. [DOI] [PubMed] [Google Scholar] · DOI
  20. McKay JR, Lynch KG, Shepard DS, Ratichek S, Morrison R, Koppenhaver J, Pettinati HM. The effectiveness of telephone-based continuing care in the clinical management of alcohol and cocaine use disorders: 12-month outcomes. J Consult Clin Psychol. 2004;72(6):967–979. doi: 10.1037/0022-006X.72.6.967. [DOI] [PubMed] [Google Scholar] · DOI
  21. McLellan AT. Editorial: Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction. 2002;97:249–252. doi: 10.1046/j.1360-0443.2002.00127.x. [DOI] [PubMed] [Google Scholar] · DOI
  22. Mee-Lee D, Gartner L, Miller MM, Shulman GD. Patient Placement Criteria for the Treatment of Substance-Related Disorders. 2. ASAM PPC-2; Chevy Chase, MD: 1996. [Google Scholar]
  23. Miller WR, editor. DHHS Publication No. (NIH) 04–5288. Bethesda, MD: NIAAA; 2004. COMBINE Monograph Series, Volume 1, Combined Behavioral Intervention Manual: A Clinical Research Guide for Therapists Treating People With Alcohol Abuse and Dependence. [Google Scholar]
  24. Murphy SA, van der Laan MJ, Robins JM CPPRG. Marginal Mean Models for Dynamic Regimes. J Am Stat Assoc. 2001;96:1410–1423. doi: 10.1198/016214501753382327. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
  25. Murphy SA. Optimal Dynamic Treatment Regimes. J R Stat Soc Ser B Methodol. 2003;65(2):331–366. [Google Scholar]
  26. Murphy SA. An experimental design for the development of adaptive treatment strategies. Stat Med. 2005;24:1455–1481. doi: 10.1002/sim.2022. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  27. Murphy SA, Oslin DW, Rush AJ, Zhu J for MCATS. Methodological Challenges in Construction Effective Treatment Sequences for Chronic Disorders. Neuropsychopharmacology. 2006 doi: 10.1038/sj.npp.1301241. in press. [DOI] [PubMed] [Google Scholar] · DOI
  28. Oslin DW, Sayers S, Ross J, Kane V, Ten Have T, Conigliaro J, Cornelius J. Disease management for depression and at-risk drinking via telephone in an older population of veterans. Psychosom Med. 2003;65(6):931–937. doi: 10.1097/01.psy.0000097335.35776.fb. [DOI] [PubMed] [Google Scholar] · DOI
  29. O'Brien CP, McLellan AT. Myths About the Treatment of Addiction. Lancet. 1996;347:237–240. doi: 10.1016/s0140-6736(96)90409-2. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  30. Pettinati HM, Volpicelli JR, Pierce JD, Jr, O'Brien CP. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J Addict Dis. 2000;19(1):71–83. doi: 10.1300/J069v19n01_06. [DOI] [PubMed] [Google Scholar] · DOI
  31. Pettinati HM, Weiss RD, Miller WR, Donovan D, Ernst DB, Rounsaville BJ. DHHS Publication No. (NIH) 04–5289. Bethesda, MD: NIAAA; 2004. COMBINE Monograph Series, Volume 2, Medical Management Treatment Manual: A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. [Google Scholar]
  32. Pineau J, Ghizaru A, Gendron-Bellemare M, Rush AJ, Murphy SA. Improving the management of chronic disorders by learning adaptive treatment strategies. 2006. Submitted. [Google Scholar]
  33. Robins JM. Optimal structural nested models for optimal sequential decisions. In: Lin DY, Haegerty P, editors. Proceedings of the Second Seattle Symposium on Biostatistics. Springer Verlag; New York: 2004. pp. 189–326. [Google Scholar]
  34. Rochon J. Issues in adjusting for covariates arising postrandomization in clinical trials. Drug Inf J. 1999;33:1219–1228. [Google Scholar]
  35. Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, Trivedi MH, Suppes T, Miller AL, Biggs MM, Shores-Wilson K, Witte BP, Shon SP, Rago WV, Altshuler KZ TMAP Research Group. Texas Medication Algorithm Project, phase 3 (TMAP-3): Rationale and Study Design. J Clin Psychiatry. 2003;64(4):357–369. doi: 10.4088/jcp.v64n0402. [DOI] [PubMed] [Google Scholar] · DOI
  36. Schneider LS, Tariot PN, Lyketsos CG, Dagerman KS, Davis KL, Davis S, Hsiao JK, Jeste DV, Katz IR, Olin JT, Pollock BG, Rabins PV, Rosenheck RA, Small GW, Lebowitz B, Lieberman JA. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Am J Geriatr Psychiatry. 2001;9(4):346–360. [PubMed] [Google Scholar]
  37. Sobell MB, Sobell LC. Stepped Care as a Heuristic Approach to the Treatment of Alcohol Problems. J Consult Clin Psychol. 2000;68(4):573–579. [PubMed] [Google Scholar]
  38. TenHave TR, Coyne J, Salzer M, Katz I. Research to improve the quality of care for depression: alternatives to the simple randomized clinical trial. Gen Hosp Psychiatry. 2003;25:115–123. doi: 10.1016/s0163-8343(02)00275-x. [DOI] [PubMed] [Google Scholar] · DOI
  39. Thall PF, Millikan RE, Sung HG. Evaluating multiple treatment courses in clinical trials. Stat Med. 2000;19:1011–1028. doi: 10.1002/(sici)1097-0258(20000430)19:8<1011::aid-sim414>3.0.co;2-m. [DOI] [PubMed] [Google Scholar] · DOI

Cited by

Sorted by citations

Authors
Murphy, S. A., Lynch, K. G., Oslin, D., McKay, J. R., & TenHave, T.
Affiliations
  • University of Michigan (US)
  • University of Pennsylvania (US)
Corresponding author
Murphy, Susan A.
Venue
Drug and Alcohol Dependence
Publisher
Elsevier BV
Published
2007-05
Volume
88
Pages
S24-S30
ISSN
0376-8716 (ISSN-L)
OpenAlex
W2108782374
Cited by
211
References
4
Citations by year
2026: 4 · 2025: 4 · 2024: 9 · 2023: 5 · 2022: 12 · 2021: 9 · 2020: 7 · 2019: 10 · 2018: 17 · 2017: 9 · 2016: 20 · 2015: 7 · 2014: 11 · 2013: 20 · 2012: 14
FWCI
8.14
Type
journal article
Language
en
Open access
Locations
  • Drug and Alcohol Dependence (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5r01aa014851-04, 5p60da005186-25)
  • National Institute on Alcohol Abuse and Alcoholism (R01 AA-014851, R01AA14850, R01AA014850, 1R01AA014851)
  • National Institute of Mental Health (R01-MH-61892, K08MH001599, P30MH052129, P30MH066270, R01MH061892, 5P30 MH 52129, K08 MH01599)
  • National Institute on Drug Abuse (DA 005186, K02DA015674, K02-DA00361, P50-DA-10075, P50DA010075, R21DA019800, P50DA005186, P60-DA005186, K02-DA15674, K02DA000361)
Topics
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
adaptive treatment strategies, substance abuse, relapse, chronic disease, sequential multiple assignment randomized trial, treatment sequencing, medication adherence, treatment burden, clinical management
MeSH terms
Algorithms, Humans, Research Design, Randomized Controlled Trials as Topic, Patient-Centered Care, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review